Document is current
Any future updates will be listed below
-
Authors
Ni, Jiaojiao
Li, Chaoqun
Xu, Xiaoqing
Xu, Qi
Yin, Qian
Chen, Hanlin
Zhou, Shurui
Li, Jingjing
Zheng, Qinhong
Xie, Yanru
Hua, Hongjun
Jin, Jianying
Xie, Tieming
Zhao, Haiping
Yan, Feng
Shen, Junjun
Huang, Yihui
Zheng, Wangye
Yan, Junrong
Wu, Xiaoying
Wang, Song
Ou, Qiuxiang
Shao, Yang
Wu, Wei
Zhuo, Wei
Ying, Jieer
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82473488)
Beijing Xisike Clinical Oncology Research Foundation (Y-HR2020MS-0934)
Zhejiang Anti-Cancer Association-Qilu Clinical Scientific Research Foundation (ziskaxhqllckyxm202208)
Natural Science Foundation of Zhejiang Province (LTGY23H160010)
"Pioneer" and "Leading Goose" R&D Program of Zhejiang (2023SDYXSO001-5)
Special Funds for Clinical Research of the National Health Commission (WKZX2023CX030001)
Medical and Health Science and Technology Program of Zhejiang Province (2021KY087)
- License Information
-
More Information
Article History
Received: 28 September 2024
Accepted: 7 July 2025
First Online: 22 July 2025
Declarations
:
: This study was approved by the Ethics Committee of the Zhejiang Cancer Hospital (Approval No.: IRB-2020–404), and in accordance with the Declaration of Helsinki. Informed consent was obtained from all the participating patients. All animal experiments were approved by the Animal Experimental Ethics Committee of Zhejiang Cancer Hospital (2023–06-014) and were performed under the guidelines for the care and use of laboratory animals.
: Not applicable.
: Hanlin Chen, Junrong Yan, Xiaoying Wu, Song Wang, Qiuxiang Ou and Yang Shao are employees of Nanjing Geneseeq Technology, Inc. All the other authors declared no conflicts of interest.
